Cancer-specific metabolism: Promising approaches for colorectal cancer treatment
1The Research Center, Metimedi Pharmaceuticals, Incheon 22006, South Korea. alvirus@naver.com.
Abstract:
Investigation of cancer-specific metabolism has made it possible to establish the principle that atypically reconstituted metabolism is considered a hallmark of cancer due to changes in physiological property. Recently, a variety of targets depending on the prompted aerobic glycolysis process, starting from the abnormal uptake of glucose, and cancer-specific metabolism due to impaired mitochondrial function and abnormal expression of drug-metabolizing enzymes have been investigated and discovered. Given that most solid cancers rely on cancer-specific metabolism to support their growth, it is necessary to examine closely the specific processes of cancer metabolism and have a detailed understanding of how cellular metabolism is altered in colorectal cancer (CRC) related to CRC survival and proliferation. The development of key methods to regulate efficiently cancer-specific metabolism in CRC is still in the initial stage. Therefore, targeting cancer-specific metabolism will yield treatable methods that are critical as a new area of development strategies for CRC treatment.
Insights
Cancer cells exhibit altered metabolism, a key hallmark of cancer, driving their growth and survival. Targeting these specific metabolic pathways in colorectal cancer (CRC) offers a promising new therapeutic strategy.
Area of Science:
- Biochemistry
- Oncology
- Metabolomics
Background:
- Cancer cells reprogram metabolism for growth, utilizing abnormal glucose uptake and impaired mitochondrial function.
- Altered cellular metabolism, including aerobic glycolysis, is a recognized hallmark of cancer.
- Dysregulated drug-metabolizing enzymes are increasingly investigated as cancer-specific targets.
Discussion:
- Colorectal cancer (CRC) relies heavily on specific metabolic alterations for survival and proliferation.
- Understanding these metabolic shifts is crucial for developing effective CRC treatments.
- Current strategies for modulating CRC metabolism are in early developmental stages.
Key Insights:
- Cancer-specific metabolism is a critical factor in tumor growth and progression.
- Investigating metabolic reprogramming provides insights into cancer hallmarks.
- Targeting metabolic pathways offers a novel therapeutic avenue for solid tumors.
Outlook:
- Developing targeted therapies for cancer-specific metabolism in CRC is a priority.
- Further research into metabolic regulation could lead to breakthrough CRC treatments.
- Modulating cancer metabolism represents a significant frontier in oncology drug development.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:18Cancer
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...